SOX11 and ductal breast carcinoma in situ: The results show a significantly higher, sustained expression of SOX11 levels compared with the previous constitutive model we have used to study DCIS progression which lost SOX11 expression over time (Figure 1—figure supplement 1; Oliemuller et al., 2017).